Kazuya Suzuki Selected Research

Dermatophagoides pteronyssinus antigen p 1

1/2012	Inhibition of allergen-induced airway inflammation by low-dose oral immunotherapy with transgenic rice seeds independently of immunoglobulin e synthesis.
12/2011	Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression.
1/2009	Development of transgenic rice expressing mite antigen for a new concept of immunotherapy.
1/2008	Generation of a transgenic rice seed-based edible vaccine against house dust mite allergy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuya Suzuki Research Topics

Disease

20	Neoplasms (Cancer) 04/2014 - 09/2002
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2012 - 02/2005
4	Carcinoma (Carcinomatosis) 03/2010 - 08/2008
3	Lung Neoplasms (Lung Cancer) 06/2012 - 10/2004
3	Hypersensitivity (Allergy) 05/2012 - 01/2008
3	Inflammation (Inflammations) 01/2012 - 06/2002
3	Adenocarcinoma 09/2011 - 05/2004
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020 - 11/2007
2	Pheochromocytoma 12/2018 - 09/2002
2	Stomach Neoplasms (Stomach Cancer) 01/2016 - 09/2011
2	Neoplasm Metastasis (Metastasis) 06/2012 - 09/2011
2	Seasonal Allergic Rhinitis (Hay Fever) 02/2012 - 11/2007
2	Asthma (Bronchial Asthma) 12/2011 - 01/2009
2	Melanoma (Melanoma, Malignant) 08/2011 - 08/2010
2	Disease Progression 08/2011 - 01/2010
2	Esophageal Neoplasms (Esophageal Cancer) 11/2010 - 06/2009
2	Adenocarcinoma of Lung 11/2007 - 10/2007
2	Prostatic Neoplasms (Prostate Cancer) 10/2006 - 02/2006
1	Arteriosclerosis 01/2021
1	Abdominal Pain (Pain, Abdominal) 12/2020
1	Infections 12/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2018
1	Multiple Endocrine Neoplasia Type 1 01/2017
1	Thrombosis (Thrombus) 04/2014
1	Syncope (Fainting) 04/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2011
1	Adenosquamous Carcinoma 09/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2011
1	Carcinogenesis 01/2011
1	Sphincter of Oddi Dysfunction 01/2011
1	Pancreatitis 01/2011
1	Esophageal Squamous Cell Carcinoma 08/2010
1	Surgical Wound Infection 08/2010
1	Circulating Neoplastic Cells 08/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2010
1	Pulmonary Embolism 01/2010
1	Polymyositis 06/2009
1	Collagen Diseases (Collagen Disease) 06/2009
1	Respiratory Insufficiency (Respiratory Failure) 06/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2011 - 11/2007
4	VaccinesIBA 05/2012 - 01/2008
4	AllergensIBA 02/2012 - 11/2007
4	Dermatophagoides pteronyssinus antigen p 1IBA 01/2012 - 01/2008
3	Immunoglobulin E (IgE)IBA 02/2012 - 11/2007
3	AntigensIBA 02/2012 - 01/2009
3	Biological ProductsIBA 09/2011 - 09/2008
2	SteroidsIBA 12/2020 - 06/2009
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2012 - 12/2011
2	Carcinoembryonic AntigenIBA 09/2011 - 05/2004
2	Tyrosine Kinase InhibitorsIBA 08/2011 - 10/2007
2	Gefitinib (Iressa)FDA Link 11/2007 - 10/2007
2	ErbB Receptors (EGF Receptor)IBA 11/2007 - 10/2007
2	Androgen Receptors (Androgen Receptor)IBA 10/2006 - 02/2006
2	AndrogensIBA 10/2006 - 02/2006
2	Dihydrotestosterone (Androstanolone)IBA 10/2006 - 02/2006
1	Capsules (Microcapsules)IBA 12/2020
1	CatecholaminesIBA 12/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	human ERBB2 proteinIBA 01/2016
1	Warfarin (Coumadin)FDA LinkGeneric 04/2014
1	Heparin (Liquaemin)FDA LinkGeneric 04/2014
1	Methylene Blue (Methylthioninium Chloride)FDA Link 03/2013
1	Dermatophagoides farinae antigen f 2IBA 05/2012
1	Subunit VaccinesIBA 12/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2011
1	Phosphotransferases (Kinase)IBA 08/2011
1	Imatinib Mesylate (Gleevec)FDA Link 08/2011
1	TubulinIBA 01/2011
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	phosphatidyl-N-monomethylaminoethanolIBA 08/2010
1	Prostaglandins AIBA 08/2010
1	Melanins (Melanin)IBA 08/2010
1	Gemcitabine FDA Link 04/2010
1	Cisplatin (Platino)FDA LinkGeneric 04/2010
1	NucleotidesIBA 03/2010
1	RNA (Ribonucleic Acid)IBA 03/2010
1	Cetuximab (Erbitux)FDA Link 01/2010
1	Ifosfamide FDA LinkGeneric 02/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2009
1	Vincristine (Oncovin)FDA LinkGeneric 02/2009
1	VimentinIBA 02/2009
1	Mesna (Coenzyme M)FDA LinkGeneric 02/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2009

Therapy/Procedure

9	Therapeutics 06/2012 - 06/2002
8	Drug Therapy (Chemotherapy) 06/2012 - 04/2003
4	Immunotherapy 01/2012 - 11/2007
3	Adjuvant Chemotherapy 09/2011 - 04/2010
2	Esophagectomy 11/2010 - 08/2010
2	Lymph Node Excision (Lymph Node Dissection) 11/2010 - 05/2004
1	Exercise Therapy (Therapy, Exercise) 01/2021
1	Segmental Mastectomy (Lumpectomy) 04/2014
1	Oral Administration 01/2012
1	Radiotherapy 08/2011
1	Sphincterotomy 01/2011
1	Stents 01/2011
1	Chemoradiotherapy 11/2010
1	Palliative Care (Palliative Therapy) 01/2010
1	Colostomy 01/2010
1	Combination Drug Therapy (Combination Chemotherapy) 02/2009